Latest Advances in Clinical Diagnosis and Treatment of Rheumatoid Arthritis
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Immunology".
Deadline for manuscript submissions: 15 November 2024 | Viewed by 1218
Special Issue Editors
2. Rheumatology Research Unit, Instituto de Medicina Molecular, Lisbon Academic Medical Centre, 1649-035 Lisbon, Portugal
Interests: rheumatoid arthritis; synovitis; Sjögren’s syndrome; clinical outcomes; biomarkers; precision medicine
2. Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, 171 76 Stockholm, Sweden.
Interests: outcomes research; clinical and observational trials; digital health; collaborative research; autoantibodies; inflammatory arthritis
Special Issue Information
Dear Colleagues,
Recent years have brought cutting-edge advancements in the clinical diagnosis and treatment of rheumatoid arthritis (RA), addressing pivotal challenges in the field. With a focus on elucidating the current research status and tackling core issues, this Special Issue aims to enhance the understanding and management of RA. Encompassing a broad scope, contributions span innovative diagnostic techniques, novel therapeutic modalities, and emerging prognostic markers. Through this Special Issue, we endeavor to foster interdisciplinary collaboration, promote knowledge dissemination, and stimulate further investigations aimed at refining RA management strategies. Together, we aspire to empower clinicians and researchers in their quest to alleviate the burden of RA and improve the quality of life for affected individuals.
Dr. Vasco C. Romão
Dr. Paul Studenic
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- rheumatoid arthritis
- diagnosis
- clinical practice
- treatment
- management
- prognosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
